6 studies were found.

1.		Completed	A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons Condition: HIV Infections
2.		Completed	A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3 Condition: HIV Infections
3.		Completed	A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma Conditions: Sarcoma, Kaposi; HIV Infections
4.		Recruiting	Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon Condition: Raynaud's Disease
5.		Recruiting	Safety and efficacy of Pletal(cilostazol) for the treatment of juvenile primary and secondary Raynaud’s phenomenon Condition: Raynaud's Disease
6.		Completed	A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease Condition: HIV Infections